UBS’s Carter's CRI Stock Holding History

UBS’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-300	Closed	-$21K	–	10403
2014 Q2	$21K	Buy	+300	New	+$21.8K	﹤0.01%	8004

Other funds holding CRI

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS's CRI Position: Q3 2014 in Review

UBS reduced its Carter's (CRI) stake by 2.5% in Q3 2014, selling an estimated $24K and leaving 11,853 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #3673.

UBS first reported a position in CRI in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.29M in Q4 2013. 229 funds tracked by Wall St. Rank hold CRI as of Q3 2014.

UBS held 11,853 shares of Carter's worth $919K as of Q3 2014.
UBS sold 310 Carter's shares in Q3 2014, an estimated $24K.
Carter's made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3673 holding.
UBS first reported a position in Carter's in Q2 2013 and has held it in 6 quarters since.
UBS's Carter's position peaked at $1.29M in Q4 2013.
229 funds tracked by Wall St. Rank held Carter's as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.